An integrated approach to workforce health, GLP-1 access, and employer financial accountability.
Explore how PayRX could help AT&T evaluate the economics of GLP-1 access, manage the timing of employer payments, coordinate clinical care, and measure workforce health outcomes before expanding the program.
Illustrative workforce and economic modeling for AT&T. Results are scenario-based and do not represent validated AT&T employee or claims data.
Pending confirmation of numerator, denominator, and measurement horizon.
Pending reconciliation with the active financial scenario.
Objective: minimize avoidable interruptions in clinically appropriate care. Not claimed as zero or guaranteed.
Strategic overview: workforce health strategy, enrollment targets, and compounding value
Eligibility, enrollment pipeline, clinical coordination, pharmacy fulfillment, and care-team interventions
Financial modeling, workforce analytics, EPS impact, and economic outlook
Commercial structures, pricing components, payment schedules, pilot design, and expansion milestones
Data architecture, privacy controls, clinical separation, audit, and AI governance
Enrollment, clinical intake, care-team interaction, consent, pharmacy coordination, and member progress
All data is synthetic and illustrative. Nothing here is validated or production data.